Isoflavones and inflammatory bowel disease.

Area of Science:

• Nutritional Science
• Gastroenterology
• Pharmacology

Background:

• Inflammatory bowel disease (IBD) encompasses ulcerative colitis and Crohn's disease, posing a significant global health challenge.
• IBD pathogenesis involves complex factors including genetics, immunity, and gut microbiota, with diet playing a crucial role.
• Isoflavones, plant-derived compounds abundant in soybeans, possess biological activities relevant to IBD.

Purpose of the Study:

• To review the multifaceted relationship between isoflavones and inflammatory bowel disease (IBD).
• To explore the potential therapeutic applications of isoflavones in managing IBD.
• To summarize current knowledge on isoflavones' effects on inflammatory pathways, intestinal barrier function, and gut flora.

Main Methods:

• Literature review of studies investigating isoflavones and IBD.
• Analysis of isoflavones' mechanisms of action, including effects on inflammatory signaling and estrogen receptors.
• Examination of dietary sources and human intake of isoflavones.

Main Results:

• Isoflavones exhibit diverse effects on IBD, with evidence suggesting both positive and negative impacts.
• Isoflavones can modulate inflammatory signal pathways, influence intestinal barrier integrity, and alter gut microbiota composition.
• Their structural similarity to estrogen allows interaction with estrogen receptors, potentially influencing IBD.

Conclusions:

• Isoflavones present a complex profile regarding their impact on IBD.
• Their dietary accessibility and varied biological activities warrant further investigation for IBD treatment strategies.
• Understanding the dual effects of isoflavones is critical for optimizing their use in IBD management.